Zelira Therapeutics Ltd: Letter to Shareholders
Zelira Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form
Zelira Therapeutics Ltd: Investor Webinar - HOPE FDA Program Update
Zelira Therapeutics Ltd: Results of Meeting
Zelira Therapeutics Ltd: 2023 Annual General Meeting Presentation
Zelira Therapeutics Ltd: Letter to Shareholders
Zelira Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form
Zelira Therapeutics Ltd: Zelira Non-Executive Director Appointed
Zelira Therapeutics Ltd: Top Line Results Investor Presentation
Zelira Therapeutics Ltd: Zelira HOPE 1 SPV Investor Presentation
Zelira Therapeutics Ltd: Zelira Executive Director Appointed
Zelira Therapeutics Ltd: HHI: Scheme implementation deed executed
Zelira Therapeutics Ltd: New Constitution
Zelira Therapeutics Ltd: Results of Meeting
Zelira Therapeutics Ltd: 2022 Annual General Meeting Presentation
Zelira Therapeutics Ltd: Zelira Retail Investor Presentation
Zelira Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form
Zelira Therapeutics Ltd: Letter to Shareholders
Zelira Therapeutics Ltd: Investor Briefing Webinar Presentation
Zelira Therapeutics Ltd: Termination of Scheme Implementation Deed with HHI
No Data
No Data